Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    A stunning’ 4% yearly rise in R&D share has emerging biopharma dominating the pipeline

    March 31, 2023

    Under pressure, biotech and pharma grapple with how to take climate action

    March 30, 2023

    Antibody-patent row could have far-reaching impact on biotech

    March 29, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      A stunning’ 4% yearly rise in R&D share has emerging biopharma dominating the pipeline

      March 31, 2023

      Under pressure, biotech and pharma grapple with how to take climate action

      March 30, 2023

      Antibody-patent row could have far-reaching impact on biotech

      March 29, 2023

      Alan Kohler: Australia’s biotech sector has suddenly got much bigger

      March 28, 2023

      Why Do So Few Biotech Startups Want To Be The Next Big Pharma Company?

      March 27, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Pharmaceutical»Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?
    Pharmaceutical

    Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

    yourbiotechBy yourbiotechNovember 7, 2022Updated:November 11, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Recovery in last hour of trade after volatility helped the benchmark indices snap two-day losing streak and closed with moderate gains on November 4. Positive global cues lifted the sentiment for investors and traders.

    The BSE Sensex climbed more than 100 points to 60,950, and the Nifty50 jumped over 60 points to 18,117 and formed a decent bullish candle on the daily charts, indicating a continuity in momentum, though there was a mixed trend in the broader market.

    The Nifty Midcap 100 index was down 0.25 percent, and Nifty Smallcap 100 index gained four-tenth of a percent. The market breadth was in favour of bulls as about 1,110 shares advanced against 863 declining shares on the NSE.

    The volatility index India VIX also cooled down below 16 mark, giving a comfort to bulls. India VIX was down by 1.8 percent at 15.66 levels.

    Stocks that were in action included Amara Raja Batteries which surged nearly 10 percent to Rs 569.4, the highest closing level since April 22 this year, and formed bullish candle on the daily charts with large volumes. It also had a strong gap up opening for the stock and also it gave a close above the previous biggest candle on February 24.

    Sun Pharma Advanced Research Company shares rallied 6 percent to Rs 260.75, the highest closing level since May 2 this year and formed long bullish candle on the daily charts with above average volumes. In fact, Friday’s bullish candle engulfed previous three days’ red candles.

    Poly Medicure was also in focus, rising 5 percent to Rs 952.5 and formed big bullish candlestick pattern on the daily charts with strong volumes. In fact, it has seen a breakout of downward sloping resistance trend line adjoining several points from the October high.

    Here’s what Jigar S Patel of Anand Rathi Shares & Stock Brokers recommends investors should do with these stocks when the market resumes trading today:

    Amara Raja Batteries

    The free fall started from January 2021 till June 2022, resulting in a 56 percent cut in the counter. On a monthly scale, it has formed an Inverted Hammer near the 0.786 retracement level of its previous up move started post covid. It has given a 11 percent return in the current month after hitting a low of Rs 437 in June 2022.

    On the indicator front, monthly MACD (moving average convergence and divergence) is about to make a bullish crossover along with monthly RSI (relative strength index) making an impulsive structure near the oversold zone of 32 levels hinting at more upside in the said counter.

    One can buy at current levels in small tranches and another at Rs 530-540 levels (if again tested). The upside is seen till Rs 650 and credible support is seen around Rs 510.

    Image134112022

    Sun Pharma Advanced Research Company

    It is a classic case of volume spread analysis. If we closely look at the monthly chart then the rally which started from April 2021 till September 2021 saw humongous volume. This clearly states that smart money was behind this buying.

    What is more interesting is that since then counter saw a 51 percent cut in price with almost slim volume (according to Volume Spread analysis which states that any correction in stocks with slim volume is just a technique used by smart money to wipe out retailers’ position).

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleViatris Acquires Oyster Point, Gains Access to Ophthalmic Pipeline
    Next Article Verve and Beam Face Regulatory Roadblocks with Next-Gen Base Editors
    yourbiotech
    • Website

    Related Posts

    Pharma company owner duped of ₹1.1 crore

    November 11, 2022

    Novavax cuts full-year revenue forecast again amid weak demand

    November 10, 2022

    Aurobindo units recall products in US market for manufacturing issues

    November 9, 2022

    AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

    November 8, 2022

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.